Merrimack Pharmaceuticals Inc (MACK)
14.72
+0.04
(+0.27%)
USD |
NASDAQ |
Apr 19, 13:55
Merrimack Pharmaceuticals Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
September 30, 2011 | -178.6% |
June 30, 2011 | -372.9% |
March 31, 2011 | -178.6% |
December 31, 2010 |
Date | Value |
---|---|
September 30, 2010 | -163.0% |
June 30, 2010 | -211.3% |
March 31, 2010 | -238.0% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 48.70% |
Palatin Technologies Inc | 95.20% |
iBio Inc | -- |
Theriva Biologics Inc | -- |
Ampio Pharmaceuticals Inc | -- |